top biopharmaceuticals for glp-1 medication 2025’s Breakthrough Obesity Treatments: Companies & Innovations 9 Companies Developing Next-Generation GLP-1

GLP-1 receptor agonists are a class of prescription medications originally developed to help manage blood sugar levels

Nat Metab

North America Glucagon-like Peptide-1 Agonists Top Companies AstraZeneca Sanofi Eli Lilly and Company Pfizer Novo Nordisk *Disclaimer: Top companies sorted in no particular order North America Glucagon-like Peptide-1 Agonists Market Concentration North America Glucagon-like Peptide-1 Agonists Company List Adocia SA Amgen AstraZeneca Boehringer Ingelheim Biocon Ltd Eli Lilly and Company Hanmi Pharmaceutical Co

In 2022, Eliquis achieved an annual revenue of $11.789 billion, representing a year-on-year growth of 10%

Behind the scenes the market leans on active pharmaceutical ingredients, peptide synthesis technologies, biologic manufacturing processes, and better drug delivery systems that keep the effect stable

In 2017, Dupixent was first approved for marketing in the United States for the treatment of atopic dermatitis